|
New Delhi, Jan 23: Seven more states will be administering the indigenously-developed Covaxin from next week, the health ministry said on Saturday.
Representational Image
The Drugs Controller General of India (DCGI) had earlier this month approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute of India, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.
Addressing a media briefing, Additional Secretary in the Union health ministry Manohar Agnani said that as on January 23, a total of 15,37,190 beneficiaries have been vaccinated for COVID-19 in 27,776 sessions.
The inoculation…
